MENY

Nationellt vårdprogram njurcancer

Fastställt av Regionala cancercentrum i samverkan, 2019-06-10

22. Referenser

About Herbs, Botanicals & Other Products Retrieved from https://www.mskcc.org/cancer-care/diagnosis-treatment/symptom-management/integrative-medicine/herbs?gclid=CjwKCAiAlvnfBRA1EiwAVOEgfOhJsxC_9cacjzXM4k5Vxq9WTuSjw9W9OGNYwlyXmksGMSECAWTZaBoCqGIQAvD_BwE

ACR Appropriateness Criteria. Retrieved from https://www.acr.org/Clinical-Resources/ACR-Appropriateness-Criteria

Ahmad, A. E., Finelli, A., & Jewett, M. A. S. (2016). Surveillance of Small Renal Masses. Urology, 98, 8-13. doi:10.1016/j.urology.2016.06.005

Alasker, A., Meskawi, M., Sun, M., Ismail, S., Hanna, N., Hansen, J., . . . Karakiewicz, P. I. (2013). A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma. Cancer Treat Rev, 39(4), 388-401. doi:10.1016/j.ctrv.2012.12.006

Bailey, D. G., Dresser, G., & Arnold, J. M. (2013). Grapefruit-medication interactions: forbidden fruit or avoidable consequences? Cmaj, 185(4), 309-316. doi:10.1503/cmaj.120951

Becker, A., Bianchi, M., Hansen, J., Tian, Z., Shariat, S. F., Popa, I., . . . Sun, M. (2014). Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample. World J Urol, 32(6), 1511-1521. doi:10.1007/s00345-014-1256-y

Bedömning och hantering av biverkningar i samband med immunterapi med checkpointhämmare (Version 22/5-2018) (2018). Retrieved from http://www.regimbiblioteket.se/dokument.html

Bex, A., Albiges, L., Ljungberg, B., Bensalah, K., Dabestani, S., Giles, R. H., . . . Powles, T. (2018). Updated European Association of Urology Guidelines for Cytoreductive Nephrectomy in Patients with Synchronous Metastatic Clear-cell Renal Cell Carcinoma. Eur Urol, 74(6), 805-809. doi:10.1016/j.eururo.2018.08.008

Bourdeanu, L., Twardowski, P., & Pal, S. K. (2011). Nursing considerations with pazopanib therapy: focus on metastatic renal cell carcinoma. Clin J Oncol Nurs, 15(5), 513-517. doi:10.1188/11.cjon.513-517

Brierley, J. D., Gospodarowicz, M. K., & Wittekind, C. (2017). TNM Classification of Malignant Tumours (Vol. 8th): Wiley-Blackwell.

Buffart, L. M., Kalter, J., Sweegers, M. G., Courneya, K. S., Newton, R. U., Aaronson, N. K., . . . Brug, J. (2017). Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs. Cancer Treat Rev, 52, 91-104. doi:10.1016/j.ctrv.2016.11.010

Cancer prevention. Retrieved from https://www.who.int/cancer/prevention/en/

Cancer Prevention Recommendations. Retrieved from https://www.wcrf.org/dietandcancer/cancer-prevention-recommendations

Cella, D., Davis, M. P., Negrier, S., Figlin, R. A., Michaelson, M. D., Bushmakin, A. G., . . . Motzer, R. J. (2014). Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma. Cancer, 120(12), 1871-1880. doi:10.1002/cncr.28660

Cho, H. S., Davis, G. C., Paek, J. E., Rao, R., Zhao, H., Xie, X. J., . . . Leitch, M. (2013). A randomised trial of nursing interventions supporting recovery of the postmastectomy patient. J Clin Nurs, 22(7-8), 919-929. doi:10.1111/j.1365-2702.2012.04100.x

Choueiri, T. K., Hessel, C., Halabi, S., Sanford, B., Michaelson, M. D., Hahn, O., . . . Morris, M. J. (2018). Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial): Progression-free survival by independent review and overall survival update. Eur J Cancer, 94, 115-125. doi:10.1016/j.ejca.2018.02.012

Curci, N., & Caoili, E. M. (2017). The Current Role of Biopsy in the Diagnosis of Renal Tumors. Semin Ultrasound CT MR, 38(1), 72-77. doi:10.1053/j.sult.2016.09.003

Dagher, J., Delahunt, B., Rioux-Leclercq, N., Egevad, L., Srigley, J. R., Coughlin, G., . . . Samaratunga, H. (2017). Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading. Histopathology, 71(6), 918-925. doi:10.1111/his.13311

Davenport, M. S., Chandarana, H., Curci, N. E., Doshi, A., Kaffenberger, S. D., Pedrosa, I., . . . Silverman, S. G. (2018). Society of Abdominal Radiology disease-focused panel on renal cell carcinoma: update on past, current, and future goals. Abdom Radiol (NY), 43(9), 2213-2220. doi:10.1007/s00261-018-1663-4

Davies, M. (2016). How Checkpoint Inhibitors Are Changing the Treatment Paradigm in Solid Tumors: What Advanced Practitioners in Oncology Need to Know. J Adv Pract Oncol, 7(5), 498-509.

Delahunt, B., Cheville, J. C., Martignoni, G., Humphrey, P. A., Magi-Galluzzi, C., McKenney, J., . . . Srigley, J. R. (2013). The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters. Am J Surg Pathol, 37(10), 1490-1504. doi:10.1097/PAS.0b013e318299f0fb

Delahunt, B., Srigley, J. R., Montironi, R., & Egevad, L. (2014). Advances in renal neoplasia: recommendations from the 2012 International Society of Urological Pathology Consensus Conference. Urology, 83(5), 969-974. doi:10.1016/j.urology.2014.02.004

Egenvård. Retrieved from https://www.cancercentrum.se/samverkan/patient-och-narstaende/egenvard/

Escudier, B., Porta, C., Schmidinger, M., Rioux-Leclercq, N., Bex, A., Khoo, V., . . . Horwich, A. (2019). Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. doi:10.1093/annonc/mdz056

Frank, I., Blute, M. L., Cheville, J. C., Lohse, C. M., Weaver, A. L., & Zincke, H. (2003). Solid renal tumors: an analysis of pathological features related to tumor size. J Urol, 170(6 Pt 1), 2217-2220. doi:10.1097/01.ju.0000095475.12515.5e

Fuhrman, S. A., Lasky, L. C., & Limas, C. (1982). Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol, 6(7), 655-663.

Ginzburg, S., Uzzo, R., Al-Saleem, T., Dulaimi, E., Walton, J., Corcoran, A., . . . Kutikov, A. (2014). Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy. J Urol, 191(2), 296-300. doi:10.1016/j.juro.2013.07.059

Gross-Goupil, M., Kwon, T. G., Eto, M., Ye, D., Miyake, H., Seo, S. I., . . . Quinn, D. I. (2018). Axitinib Versus Placebo as an Adjuvant Treatment for Renal Cell Carcinoma: Results From the Phase III, Randomized ATLAS Trial. Ann Oncol. doi:10.1093/annonc/mdy454

Guethmundsson, E., Hellborg, H., Lundstam, S., Erikson, S., & Ljungberg, B. (2011). Metastatic potential in renal cell carcinomas </=7 cm: Swedish Kidney Cancer Quality Register data. Eur Urol, 60(5), 975-982. doi:10.1016/j.eururo.2011.06.029

Guidelines. Renal Cell Carcinoma. Retrieved from http://uroweb.org/guideline/renal-cell-carcinoma/

Helck, A., Schonermarck, U., Habicht, A., Notohamiprodjo, M., Stangl, M., Klotz, E., . . . Becker, C. (2014). Determination of split renal function using dynamic CT-angiography: preliminary results. PLoS One, 9(3), e91774. doi:10.1371/journal.pone.0091774

Henry, D. H., Costa, L., Goldwasser, F., Hirsh, V., Hungria, V., Prausova, J., . . . Yeh, H. (2011). Randomized, double-blind study of denosumab versus zoledronic acid in the treatment of bone metastases in patients with advanced cancer (excluding breast and prostate cancer) or multiple myeloma. J Clin Oncol, 29(9), 1125-1132. doi:10.1200/jco.2010.31.3304

Herrera-Caceres, J. O., Finelli, A., & Jewett, M. A. S. (2018). Renal tumor biopsy: indicators, technique, safety, accuracy results, and impact on treatment decision management. World J Urol. doi:10.1007/s00345-018-2373-9

Hindman, N. M. (2018). Imaging of Cystic Renal Masses. Urol Clin North Am, 45(3), 331-349. doi:10.1016/j.ucl.2018.03.006

Hovan, A. J., Williams, P. M., Stevenson-Moore, P., Wahlin, Y. B., Ohrn, K. E., Elting, L. S., . . . Brennan, M. T. (2010). A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer, 18(8), 1081-1087. doi:10.1007/s00520-010-0902-1

Hälso- och sjukvårdslag (2017:30).  Retrieved from https://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/halso--och-sjukvardslag_sfs-2017-30

Integrativ medicin. Retrieved from https://www.cancercentrum.se/stockholm-gotland/vara-uppdrag/vardprocesser/integrativ-cancervard/

Iwakawa, M., Noda, S., Yamada, S., Yamamoto, N., Miyazawa, Y., Yamazaki, H., . . . Imai, T. (2006). Analysis of non-genetic risk factors for adverse skin reactions to radiotherapy among 284 breast cancer patients. Breast Cancer, 13(3), 300-307.

Jagsi, R., Griffith, K. A., Koelling, T., Roberts, R., & Pierce, L. J. (2007). Rates of myocardial infarction and coronary artery disease and risk factors in patients treated with radiation therapy for early-stage breast cancer. Cancer, 109(4), 650-657. doi:10.1002/cncr.22452

Kaufman, E. L., Jacobson, J. S., Hershman, D. L., Desai, M., & Neugut, A. I. (2008). Effect of breast cancer radiotherapy and cigarette smoking on risk of second primary lung cancer. J Clin Oncol, 26(3), 392-398. doi:10.1200/jco.2007.13.3033

Kay, F. U., & Pedrosa, I. (2018). Imaging of Solid Renal Masses. Urol Clin North Am, 45(3), 311-330. doi:10.1016/j.ucl.2018.03.013

Keulers, B. J., Scheltinga, M. R., Houterman, S., Van Der Wilt, G. J., & Spauwen, P. H. (2008). Surgeons underestimate their patients' desire for preoperative information. World J Surg, 32(6), 964-970. doi:10.1007/s00268-008-9581-1

Kontaktsjuksköterska. Retrieved from http://cancercentrum.se/samverkan/patient-och-narstaende/kontaktsjukskoterska/

Kotronoulas, G., Kearney, N., Maguire, R., Harrow, A., Di Domenico, D., Croy, S., & MacGillivray, S. (2014). What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. J Clin Oncol, 32(14), 1480-1501. doi:10.1200/jco.2013.53.5948

KVAST-dokument. Urologisk patologi. Retrieved from http://www.svfp.se/kvastdokument%5E15

Lardas, M., Stewart, F., Scrimgeour, D., Hofmann, F., Marconi, L., Dabestani, S., . . . Lam, T. B. (2016). Systematic Review of Surgical Management of Nonmetastatic Renal Cell Carcinoma with Vena Caval Thrombus. Eur Urol, 70(2), 265-280. doi:10.1016/j.eururo.2015.11.034

Lithner, M., Zilling T. (1998). Does preoperative information increase the wellbeing of the patient after surgery? (in Swedish). Vård i Norden 1998; 18:31-33,39, 1998.18, 31-33, 39.

Lutz, S., Balboni, T., Jones, J., Lo, S., Petit, J., Rich, S. E., . . . Hahn, C. (2017). Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline. Pract Radiat Oncol, 7(1), 4-12. doi:10.1016/j.prro.2016.08.001

Macdonald, G., Kondor, N., Yousefi, V., Green, A., Wong, F., & Aquino-Parsons, C. (2004). Reduction of carboxyhaemoglobin levels in the venous blood of cigarette smokers following the administration of carbogen. Radiother Oncol, 73(3), 367-371. doi:10.1016/j.radonc.2004.09.002

Malekzadeh, F., et al. (2005). Naturläkemedel och hormonpreparat - potentiell risk för bröstcancerpatienter 102.

Marconi, L., Dabestani, S., Lam, T. B., Hofmann, F., Stewart, F., Norrie, J., . . . Volpe, A. (2016). Systematic Review and Meta-analysis of Diagnostic Accuracy of Percutaneous Renal Tumour Biopsy. Eur Urol, 69(4), 660-673. doi:10.1016/j.eururo.2015.07.072

Mejean, A., Ravaud, A., Thezenas, S., Colas, S., Beauval, J. B., Bensalah, K., . . . Escudier, B. (2018). Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma. N Engl J Med, 379(5), 417-427. doi:10.1056/NEJMoa1803675

Min vårdplan i cancervården. Retrieved from https://www.cancercentrum.se/samverkan/patient-och-narstaende/min-vardplan/

Mishra, S. I., Scherer, R. W., Geigle, P. M., Berlanstein, D. R., Topaloglu, O., Gotay, C. C., & Snyder, C. (2012). Exercise interventions on health-related quality of life for cancer survivors. Cochrane Database Syst Rev(8), Cd007566. doi:10.1002/14651858.CD007566.pub2

Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E., & Ulbright, T. M. (2016). The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. Eur Urol, 70(1), 93-105. doi:10.1016/j.eururo.2016.02.029

Monn, M. F., Bahler, C. D., Flack, C. K., Dube, H. T., & Sundaram, C. P. (2014). The impact of hospital volume on postoperative complications following robot-assisted partial nephrectomy. J Endourol, 28(10), 1231-1236. doi:10.1089/end.2014.0265

Motzer, R. J., Nosov, D., Eisen, T., Bondarenko, I., Lesovoy, V., Lipatov, O., . . . Hutson, T. E. (2013). Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial. J Clin Oncol, 31(30), 3791-3799. doi:10.1200/jco.2012.47.4940

Motzer, R. J., Ravaud, A., Patard, J. J., Pandha, H. S., George, D. J., Patel, A., . . . Staehler, M. (2018). Adjuvant Sunitinib for High-risk Renal Cell Carcinoma After Nephrectomy: Subgroup Analyses and Updated Overall Survival Results. Eur Urol, 73(1), 62-68. doi:10.1016/j.eururo.2017.09.008

Myers, K., Hajek, P., Hinds, C., & McRobbie, H. (2011). Stopping smoking shortly before surgery and postoperative complications: a systematic review and meta-analysis. Arch Intern Med, 171(11), 983-989. doi:10.1001/archinternmed.2011.97

Nationella Regimbiblioteket. Retrieved from http://regimbiblioteket.cancercentrum.se/

Nationella riktlinjer för prevention och behandling vid ohälsosamma levnadsvanor – Stöd för styrning och ledning (2018). Retrieved fromhttps://www.socialstyrelsen.se/publikationer2018/2018-6-24

Nationellt vårdprogram för Akut Onkologi. (2018). Retrieved from http://www.cancercentrum.se/samverkan/cancerdiagnoser/overgripande-kunskapsstod/nationellt-vardprogram-akut-onkologi/

Oppedal, K., Moller, A. M., Pedersen, B., & Tonnesen, H. (2012). Preoperative alcohol cessation prior to elective surgery. Cochrane Database Syst Rev(7), Cd008343. doi:10.1002/14651858.CD008343.pub2

Patel, H. D., Druskin, S. C., Rowe, S. P., Pierorazio, P. M., Gorin, M. A., & Allaf, M. E. (2017). Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis. BJU Int, 119(5), 661-666. doi:10.1111/bju.13763

Patientinformation Njurcancer. Retrieved from https://www.cancercentrum.se/stockholm-gotland/cancerdiagnoser/urinvagar/njurcancer/

Patientlag 2014:821.  Retrieved from http://www.riksdagen.se/sv/dokument-lagar/dokument/svensk-forfattningssamling/patientlag-2014821_sfs-2014-821

Peterson, C. (2005). [Natural remedies--self care at your own risk! Danger of unknown adverse effects and interactions with "common" medications]. Lakartidningen, 102(44), 3200-3201.

Prochazka, M., Granath, F., Ekbom, A., Shields, P. G., & Hall, P. (2002). Lung cancer risks in women with previous breast cancer. Eur J Cancer, 38(11), 1520-1525.

R.E.N.A.L Nephrometry Scoring System. Retrieved from http://www.nephrometry.com/

Rabow, M. W., Benner, C., Shepard, N., & Meng, M. V. (2015). Concurrent urologic and palliative care after cystectomy for treatment of muscle-invasive bladder cancer. Urol Oncol, 33(6), 267.e223-269. doi:10.1016/j.urolonc.2015.02.012

Raising awareness of the link between alcohol and cancer. Retrieved from http://www.euro.who.int/en/health-topics/disease-prevention/alcohol-use/news/news/2018/02/raising-awareness-of-the-link-between-alcohol-and-cancer

Richard, P. O., Violette, P. D., Jewett, M. A., Pouliot, F., Leveridge, M., So, A., . . . Finelli, A. (2017). CUA guideline on the management of cystic renal lesions. Can Urol Assoc J, 11(3-4), E66-e73. doi:10.5489/cuaj.4484

Rini, B. I., Plimack, E. R., Stus, V., Gafanov, R., Hawkins, R., Nosov, D., . . . Powles, T. (2019). Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med, 380(12), 1116-1127. doi:10.1056/NEJMoa1816714

Roila, F., Molassiotis, A., Herrstedt, J., Aapro, M., Gralla, R. J., Bruera, E., . . . van der Wetering, M. (2016). 2016 MASCC and ESMO guideline update for the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting and of nausea and vomiting in advanced cancer patients. Ann Oncol, 27(suppl 5), v119-v133. doi:10.1093/annonc/mdw270

Rossi, S. H., Prezzi, D., Kelly-Morland, C., & Goh, V. (2018). Imaging for the diagnosis and response assessment of renal tumours. World J Urol. doi:10.1007/s00345-018-2342-3

Rubinsky, A. D., Sun, H., Blough, D. K., Maynard, C., Bryson, C. L., Harris, A. H., . . . Bradley, K. A. (2012). AUDIT-C alcohol screening results and postoperative inpatient health care use. J Am Coll Surg, 214(3), 296-305.e291. doi:10.1016/j.jamcollsurg.2011.11.007

Schmitz, K. H., Courneya, K. S., Matthews, C., Demark-Wahnefried, W., Galvao, D. A., Pinto, B. M., . . . Schwartz, A. L. (2010). American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc, 42(7), 1409-1426. doi:10.1249/MSS.0b013e3181e0c112

Schoots, I. G., Zaccai, K., Hunink, M. G., & Verhagen, P. (2017). Bosniak Classification for Complex Renal Cysts Reevaluated: A Systematic Review. J Urol, 198(1), 12-21. doi:10.1016/j.juro.2016.09.160

Segers, H., van den Heuvel-Eibrink, M. M., Pritchard-Jones, K., Coppes, M. J., Aitchison, M., Bergeron, C., . . . Warwick, A. B. (2011). Management of adults with Wilms' tumor: recommendations based on international consensus. Expert Rev Anticancer Ther, 11(7), 1105-1113. doi:10.1586/era.11.76

Sharp, L., Johansson, H., Hatschek, T., & Bergenmar, M. (2013). Smoking as an independent risk factor for severe skin reactions due to adjuvant radiotherapy for breast cancer. Breast, 22(5), 634-638. doi:10.1016/j.breast.2013.07.047

Skalski, M. Diagram - Bosniak classification of renal cysts. Case courtesy of  Dr Matt Skalski, Radiopaedia.org, rID: 20989. Retrieved from https://radiopaedia.org/cases/diagram-bosniak-classification-of-renal-cysts

Socialdepartementet. (2009). En nationell cancerstrategi för framtiden, SOU 2009:11. Stockholm: Fritzes offentliga publikationer

Stenman, M., Sinclair, G., Paavola, P., Wersall, P., Harmenberg, U., & Lindskog, M. (2018). Overall survival after stereotactic radiotherapy or surgical metastasectomy in oligometastatic renal cell carcinoma patients treated at two Swedish centres 2005-2014. Radiother Oncol, 127(3), 501-506. doi:10.1016/j.radonc.2018.04.028

Stephensen, D., Hashem, F., Corbett, K., Bates, A., George, M., Hobbs, R. P., . . . Ali, H. (2018). Effects of preoperative and postoperative resistance exercise interventions on recovery of physical function in patients undergoing abdominal surgery for cancer: a systematic review of randomised controlled trials. BMJ Open Sport Exerc Med, 4(1), e000331. doi:10.1136/bmjsem-2017-000331

Sternberg, C. N., Calabro, F., Bracarda, S., Carteni, G., Lo Re, G., Ruggeri, E. M., . . . Porta, C. (2015). Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial. Oncology, 88(5), 273-280. doi:10.1159/000369256

Sun, M., Bianchi, M., Trinh, Q. D., Abdollah, F., Schmitges, J., Jeldres, C., . . . Karakiewicz, P. I. (2012). Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy. J Urol, 187(2), 405-410. doi:10.1016/j.juro.2011.10.025

Thorstenson, A., Bergman, M., Scherman-Plogell, A. H., Hosseinnia, S., Ljungberg, B., Adolfsson, J., & Lundstam, S. (2014). Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol, 48(3), 231-238. doi:10.3109/21681805.2013.864698

Tsivian, M., Rampersaud, E. N., Jr., del Pilar Laguna Pes, M., Joniau, S., Leveillee, R. J., Shingleton, W. B., . . . Polascik, T. J. (2014). Small renal mass biopsy--how, what and when: report from an international consensus panel. BJU Int, 113(6), 854-863. doi:10.1111/bju.12470

van der Werf, A., Rovithi, M., Langius, J. A. E., de van der Schueren, M. A. E., & Verheul, H. M. W. (2017). Insight in taste alterations during treatment with protein kinase inhibitors. Eur J Cancer, 86, 125-134. doi:10.1016/j.ejca.2017.09.006

Ward, R. D., & Remer, E. M. (2018). Cystic renal masses: An imaging update. Eur J Radiol, 99, 103-110. doi:10.1016/j.ejrad.2017.12.015

Wells, M., Macmillan, M., Raab, G., MacBride, S., Bell, N., MacKinnon, K., . . . Munro, A. (2004). Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial. Radiother Oncol, 73(2), 153-162. doi:10.1016/j.radonc.2004.07.032

Vårdplan och behandlingsinformation till patienter med njurcancer. Retrieved from http://www.cancercentrum.se/stockholm-gotland/cancerdiagnoser/urinvagar/njurcancer/stod-vid-information/

Yap, S. A., Horovitz, D., Alibhai, S. M., Abouassaly, R., Timilshina, N., & Finelli, A. (2012). Predictors of early mortality after radical nephrectomy with renal vein or inferior vena cava thrombectomy - a population-based study. BJU Int, 110(9), 1283-1288. doi:10.1111/j.1464-410X.2012.11125.x